跳至主要内容
临床试验/NCT05269225
NCT05269225招募中不适用

Organic Diet in Pregnancy and Risk Markers of Health Effects

Per Ole Iversen, MD2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年5月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
2
主要终点
Maternal urinary excretion level of dialkylphosphates

研究概览

简要总结

The OrgDiet project is a two-armed (1:1), open, intention-to-treat randomized controlled trial. The aim is to examine effects of consumption of organic foods (intervention group) vs. conventional foods (control group) during pregnancy in both mother and child. About 100 participants will be included and the participants will be followed until the children are two years old. Both groups will also be recommended to eat according to the dietary guidelines of the Directory of Health in Norway.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • Nulli- or multipara pregnant in first trimester

排除标准

  • Consuming an organic diet regularly
  • Using medication regularly that might interfere with study adherence or - outcomes
  • Diagnosed with a chronic disorder or cancer
  • Having a food allergy or intolerance

结局指标

主要结局

Maternal urinary excretion level of dialkylphosphates

时间窗: 2.5 years

The difference in maternal urinary excretion level of these pesticides at the end of intervention (gestational week 37) between the intervention group and the control group, measured at baseline (gestational week 12-14), and at several occasions until 2 years after the birth of the baby.

次要结局

  • Abundance and species-types of gut microbiota (e.g. staphylococci and enterobacter) sampled from stool samples(2.5 years)
  • Child body length(2 years)
  • Child body weight(2 years)
  • Blood concentration HbA1c(2.5 years)
  • DNA methylation patterns in leucocytes as a marker of altered epigenetic programming(2.5 years)
  • Blood concentration of cholesterol(2.5 years)
  • Child urinary excretion level of dialkylphosphates(2 years)
  • Blood concentration CRP(2.5 years)

研究者

发起方
Per Ole Iversen, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Per Ole Iversen, MD

Professor

University of Oslo

研究点 (2)

Loading locations...

相似试验